DACH1 A Key Protein For Tumor Suppression In ER+ Breast Cancer, Kimmel Cancer Institute Study

Published: Jul 15, 2009

Bookmark and Share

ScienceDaily (July 15, 2009) — Researchers from the Kimmel Cancer Center at Jefferson have identified a protein relationship that may be an ideal treatment target for ER+ breast cancer. The study was reported in the July 15 issue of Cancer Research.

Back to news